Quarterly Financial Reports and Upcoming Earnings and Conferences Call Schedules - Research Report on St. Jude Medical, Varian, Techne, DexCom, and Hill-Rom
NEW YORK, October 28, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts Corner announced new research reports highlighting St. Jude Medical Inc. (NYSE: STJ), Varian Medical Systems, Inc. (NYSE: VAR), Techne Corp. (NASDAQ: TECH), DexCom, Inc. (NASDAQ: DXCM), and Hill-Rom Holdings, Inc. (NYSE: HRC). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
St. Jude Medical Inc. Research Report
On October 16, 2013, St. Jude Medical Inc. (St. Jude Medical) reported its Q3 2013 results. The Company posted net sales for the quarter of $1.3 billion, representing an increase of 0.9% YoY. Net earnings attributable to the Company stood at $262 million $0.90 per diluted share in Q3 2013, compared to $176 million or $0.56 per diluted share in Q3 2012. St. Jude Medical reported non-GAAP net earnings of $262 million or $0.90 per diluted share during the quarter, compared to $261 million or $0.83 per diluted share in Q3 2012. According to the Company, it expects Q4 2013 revenue to be in the range of $1.31 billion to $1.39 billion; full-year 2013 revenue to be in the range of $5.39 billion to $5.47 billion; Q4 2013 consolidated adjusted EPS to be within $0.95 to $0.97; and full-year 2013 adjusted EPS to be between $3.72 and $3.74. The Full Research Report on St. Jude Medical Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/b338_STJ]
--
Varian Medical Systems, Inc. Research Report
On October 23, 2013, Varian Medical Systems, Inc. (Varian) announced that it will host a full-year FY 2013 review for investors on November 5, 2013 at the Marriott Marquis, 1535 Broadway, New York, from 11:30 a.m. ET to 1:00 p.m. ET. Varian informed that its management team comprising of President and CEO, Dow Wilson; Kolleen Kennedy, Senior Vice President and President of Oncology Systems; Elisha Finney, Executive Vice President and CFO; and Spencer Sias, Vice President, Investor Relations will participate in the event. The Company stated that a webcast of the meeting and its archive will be available at its Investor Relations website. The Full Research Report on Varian Medical Systems, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/bd48_VAR]
--
Techne Corp. Research Report
On October 23, 2013, Techne Corp. (Techne) announced that it will host its Q1 FY 2014 conference call to review its quarterly results on Tuesday, October 29, 2013, at 7:30 a.m. CDT. Techne stated that the replay of the call will be available for interested parties at its website under the events section from 5:00 PM CDT on October 29th, 2013 until 5:00 PM CDT on November 29th, 2013. The Full Research Report on Techne Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/b071_TECH]
--
DexCom, Inc. Research Report
On October 23, 2013, DexCom, Inc. (DexCom) announced that it intends to release its Q3 2013 results after market close on Wednesday, November 6, 2013. The Company informed that it will also host a conference call to discuss its quarterly results on the same day at 4:30 p.m. ET. The Company stated that a webcast of the live call and its replay will be available at its Investor Relations website. The Full Research Report on DexCom, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/d377_DXCM]
--
Hill-Rom Holdings, Inc. Research Report
On October 23, 2013, Hill-Rom Holdings, Inc. (Hill-Rom) released its Q4 FY 2013 and full-year FY 2013 results (period ended September 30, 2013). The Company registered net revenues of $437.9 million, up 1.5% YoY in Q4 FY 2013, while revenues for full-year FY 2013 increased 5.0% YoY to $1.7 billion. Net income for the quarter stood at $35.3 million or $0.59 per diluted share, compared to $39.2 million or $0.63 per diluted share in Q4 FY 2013. For full-year FY 2013, net income arrived at $105.0 million or $1.74 per diluted share, compared to $120.8 million or $1.94 per diluted share in full-year FY 2012. John Greisch, President and CEO, Hill-Rom, commented, "Although pleased with our strong fourth quarter results, we continue to see uneven capital order trends, particularly in our North America business. Accordingly, we remain cautious as we move into 2014, where we expect to continue to have quarterly fluctuations in capital revenue." Hill-Rom expects full- year FY 2014 revenue growth of approximately 1% and Q1 FY 2014 revenue to decline by approximately 5% to 6 % on constant currency basis. The Company further anticipates adjusted diluted EPS to be in the range of $2.43 to $2.51 for full-year FY 2014 and $0.50 to $0.52 for Q1 FY 2014.The Full Research Report on Hill-Rom Holdings, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.AnalystsCorner.com/r/full_research_report/777e_HRC]
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts' Corner
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article